Alici, S. Et Al. 2003. Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC). AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.26, no.4 , 358-362.

Alici, S., Saip, P., Eralp, Y., Aydiner, A., & Topuz, E., (2003). Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC). AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.26, no.4, 358-362.

Alici, S Et Al. "Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC)," AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.26, no.4, 358-362, 2003

Alici, S Et Al. "Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC)." AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.26, no.4, pp.358-362, 2003

Alici, S. Et Al. (2003) . "Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC)." AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.26, no.4, pp.358-362.

@article{article, author={S Alici Et Al. }, title={Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC)}, journal={AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS}, year=2003, pages={358-362} }